PubRank

Stefan Aufderklamm

Author PubWeight™ 14.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Y pouch neobladder-a simplified method of intracorporeal neobladder after robotic cystectomy. J Endourol 2014 1.51
2 Urethral ultrasound as a screening tool for stricture recurrence after oral mucosa graft urethroplasty. Urology 2011 1.50
3 Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria. Adv Urol 2011 1.49
4 Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer. Urology 2012 1.47
5 Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients. Anticancer Res 2012 0.87
6 Influence of renal excretory function on the performance of urine based markers to detect bladder cancer. J Urol 2011 0.87
7 Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma. Urol Oncol 2011 0.86
8 Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. Cancer Cytopathol 2012 0.86
9 Individual risk assessment in bladder cancer patients based on a multi-marker panel. J Cancer Res Clin Oncol 2012 0.81
10 Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression? World J Urol 2012 0.80
11 Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure. World J Surg Oncol 2015 0.79
12 Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer. Prostate 2015 0.78
13 Upper urinary tract laparoendoscopic single-site surgery based on a novel cost-effective reusable platform. J Endourol 2012 0.75
14 Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. Prostate 2012 0.75
15 The chance of small interfering RNAs as eligible candidates for a personalized treatment of prostate cancer. Curr Pharm Biotechnol 2014 0.75
16 Surgical removal of retroperitoneal tumors after chemotherapy treated testicular tumors. Curr Urol Rep 2014 0.75
17 Small interfering RNA transfection against serum response factor mediates growth inhibition of benign prostatic hyperplasia fibroblasts. Nucleic Acid Ther 2013 0.75
18 Return to Work and Normal Daily Life Activity after Open and Robot-Assisted Radical Prostatectomy - A Single Surgeon Analysis. Urol Int 2016 0.75
19 Endoscopic inguinofemoral lymphadenectomy--extended follow-up. J Endourol 2012 0.75
20 Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. BJU Int 2013 0.75